UniQure's AMT-130 Gene Therapy Success in Huntington's Disease

AMT-130 gene therapy for Huntington’s disease showed major success, statistically slowing progression by 75%. Experts see disease-modifying potential. It was well-tolerated. UniQure secured funding for a planned late 2026 U.S. launch.